Related Experiment Videos
[Antihypertensive therapy optimization and endothelial function in patients with gout and chronic urate
Insights
Combination antihypertensive therapy effectively treats endothelial dysfunction in patients with gout and chronic urate tubulointestinal nephritis (UTIN). This treatment reduces microalbuminuria and endothelin-1 levels, improving kidney function and blood pressure.
Area of Science:
- Nephrology
- Cardiology
- Rheumatology
Background:
- Chronic urate tubulointestinal nephritis (UTIN) and articular gout are associated with endothelial dysfunction.
- Patients often exhibit microalbuminuria (MAU) and elevated serum endothelin-1 (ET-1) levels, indicating renal damage and impaired endothelial function.
- Arterial hypertension is common in these patients, further exacerbating cardiovascular and renal risks.
Purpose of the Study:
- To characterize markers of endothelial dysfunction in patients with UTIN and articular gout.
- To evaluate the impact of antihypertensive drugs on these markers.
- To assess the efficacy of combination therapy in managing hypertension and endothelial dysfunction.
Main Methods:
- Study included 81 patients (39-59 years) with gout, urate nephropathy, and grade 1-2 hypertension.
- Monitored glomerular filtration rate (GFR), MAU, and serum ET-1 levels.
- Patients received 12 months of combination therapy with ACE inhibitors/ARBs and calcium channel blockers.
Main Results:
- All patients presented with MAU and elevated ET-1 before treatment.
- Combination therapy significantly reduced albuminuria and ET-1 concentrations.
- Antihypertensive treatment lowered blood pressure and increased GFR, indicating improved renal function.
Conclusions:
- Combination antihypertensive therapy, including ACE inhibitors or ARBs, effectively resolves endothelial dysfunction markers in patients with gout and UTIN.
- This therapeutic approach improves renal function and blood pressure control.
- The findings highlight the importance of managing hypertension to mitigate endothelial dysfunction in this patient population.
Aim:
to characterize the markers of endothelial dysfunction and the effect of antihypertensive drugs on them in patients with chronic urate tubulointestinal nephritis (UTIN) and articular gout.
Subjects And Methods:
The study enrolled 81 patients aged 39 to 59 years with gout and urate nephropathy. All the patients were diagnosed as having grade 1-2 arterial hypertension. A lower glomerular filtration rate (GFR) was noted in 49.9%; microalbuminuria (MAU) and elevated serum endothelin-1 (ET-1) levels were recorded in all the patients. Combination antihypertensive therapy based on the use of angiotensin-converting enzyme (ACE) inhibitors and/or an angiotensin II receptor blocker (ARB) in combination with calcium channel blockers was performed during 12 months. The time course of changes in blood pressure, the parameters of target organ lesion, and the markers of endothelial dysfunction were monitored.
Results:
Before the study, all the examinees were found to have MAU and increased serum ET-1, which are regarded simultaneously as signs of renal lesion and as markers of endothelial function. A combination of an ACE inhibitor or an ARB could diminish albuminuria and reduce ET-1 concentrations, lower systolic and diastolic blood pressure significantly, and increase GFR.
Conclusion:
The patients with articular gout and chronic UTIN are observed to have signs of endothelial dysfunction eliminated by combination antihypertensive therapy.
Related Concept Videos
Antihypertensive Drugs: Action of Diuretics
Hypertension IV: Drug Therapy and Lifestyle Modifications
Urinary Tract Calculi IV: Nutrition Therapy and Prevention
Nephrotic Syndrome II : Assessment and Medical Management
Antihypertensive Drugs: Direct Renin Inhibitors
Urinary Tract Calculi III: Medical Management